Reports for TEVA-DUTASTERIDE
Brand name
TEVA-DUTASTERIDE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02408287 |
Ingredients
DUTASTERIDE |
Ingredient Strength
0.5 MG |
ATC Code
G04CB |
ATC Descriptor
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-DUTASTERIDE | 30 | Resolved | 2017-04-03 | 2019-01-03 | 5189 |
| TEVA-DUTASTERIDE | 100 | Resolved | 2017-04-03 | 2019-01-03 | 5192 |
| TEVA-DUTASTERIDE | 100 | Resolved | 2019-10-03 | 2019-10-10 | 95370 |
| TEVA-DUTASTERIDE | 30 | Resolved | 2022-09-07 | 2023-10-05 | 168733 |
| TEVA-DUTASTERIDE | 100 | Actual shortage | 2023-02-09 | 2024-04-25 | 184216 |
| TEVA-DUTASTERIDE | 30 | Resolved | 2023-06-16 | 2023-07-05 | 195164 |
| TEVA-DUTASTERIDE | 100 | Resolved | 2023-06-20 | 2023-07-05 | 195775 |
| TEVA-DUTASTERIDE | pp 30 | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
Showing 1 to 8 of 8
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0